Literature DB >> 25124889

Seeking a measure of clinically meaningful change in ALS.

Martin McElhiney1, Judith G Rabkin, Raymond Goetz, Jonathan Katz, Robert G Miller, Dallas A Forshew, William David, Merit Cudkowicz, Jonathan D Glass, Stanley Appel, Ericka Simpson, Hiroshi Mitsumoto.   

Abstract

We sought to identify a method to assess 'clinically meaningful change' perceived by patients, caregivers and clinical raters in relation to changes in ALSFRS-R scores at three-month intervals. In this five-site study, 81 patient-caregiver dyads were interviewed at baseline, three, and six months to assess changes in ALSFRS-R in relation to perceived occurrence of change, its magnitude and impact. Ratings by patients, caregivers and clinical raters were analyzed over three-month intervals within and between respondent groups. We found that patients, clinical raters, and caregivers agreed about 80% of the time about whether change occurred, and in what direction, on each of three visits. The perceived magnitude of change for the four domains measured by the ALSFRS-R was correlated with ratings of impact within respondent groups and across time. We also found moderate associations between changes in ALSFRS-R domain scores and judgments of symptom impact as rated by patient, caregiver and clinical rater. Independent measures (Quality of Life, Goal Assessment Scaling) showed no consistent correlations with ALSFRS-R change scores. In conclusion, the use of scales to assess the perceived magnitude and impact of change corresponding with the domains of the ALSFRS-R may be a step towards understanding of the clinical meaning of changes in that measure.

Entities:  

Keywords:  ALSFRS-R; Clinically meaningful changes; quality of life

Mesh:

Year:  2014        PMID: 25124889     DOI: 10.3109/21678421.2014.942668

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  3 in total

Review 1.  Patient-Perceived Outcomes and Quality of Life in ALS.

Authors:  Zachary Simmons
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

2.  Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis.

Authors:  Jordan R Green; Kristen M Allison; Claire Cordella; Brian D Richburg; Gary L Pattee; James D Berry; Eric A Macklin; Erik P Pioro; Richard A Smith
Journal:  Br J Clin Pharmacol       Date:  2018-10-01       Impact factor: 4.335

3.  Combined respiratory training in an individual with C9orf72 amyotrophic lateral sclerosis.

Authors:  Raele Robison; Lauren C Tabor-Gray; James P Wymer; Emily K Plowman
Journal:  Ann Clin Transl Neurol       Date:  2018-08-21       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.